Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma (original) (raw)

Nature Genetics volume 44, pages 765–769 (2012)Cite this article

Subjects

Abstract

To survey hepatitis B virus (HBV) integration in liver cancer genomes, we conducted massively parallel sequencing of 81 HBV-positive and 7 HBV-negative hepatocellular carcinomas (HCCs) and adjacent normal tissues. We found that HBV integration is observed more frequently in the tumors (86.4%) than in adjacent liver tissues (30.7%). Copy-number variations (CNVs) were significantly increased at HBV breakpoint locations where chromosomal instability was likely induced. Approximately 40% of HBV breakpoints within the HBV genome were located within a 1,800-bp region where the viral enhancer, X gene and core gene are located. We also identified recurrent HBV integration events (in ≥4 HCCs) that were validated by RNA sequencing (RNA-seq) and Sanger sequencing at the known and putative cancer-related TERT, MLL4 and CCNE1 genes, which showed upregulated gene expression in tumor versus normal tissue. We also report evidence that suggests that the number of HBV integrations is associated with patient survival.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Accession codes

Primary accessions

Gene Expression Omnibus

Referenced accessions

NCBI Reference Sequence

References

  1. Center, M.M. & Jemal, A. International trends in liver cancer incidence rates. Cancer Epidemiol. Biomarkers Prev. 20, 2362–2368 (2011).
    Article PubMed Google Scholar
  2. But, D.Y., Lai, C.L. & Yuen, M.F. Natural history of hepatitis-related hepatocellular carcinoma. World J. Gastroenterol. 14, 1652–1656 (2008).
    Article PubMed PubMed Central Google Scholar
  3. Ishikawa, T. Clinical features of hepatitis B virus–related hepatocellular carcinoma. World J. Gastroenterol. 16, 2463–2467 (2010).
    Article PubMed PubMed Central Google Scholar
  4. Bréchot, C., Gozuacik, D., Murakami, Y. & Paterlini-Brechot, P. Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin. Cancer Biol. 10, 211–231 (2000).
    Article PubMed Google Scholar
  5. Zucman-Rossi, J. & Laurent-Puig, P. Genetic diversity of hepatocellular carcinomas and its potential impact on targeted therapies. Pharmacogenomics 8, 997–1003 (2007).
    Article CAS PubMed Google Scholar
  6. Gehring, A.J. et al. Profile of tumor antigen–specific CD8 T cells in patients with hepatitis B virus–related hepatocellular carcinoma. Gastroenterology 137, 682–690 (2009).
    Article CAS PubMed Google Scholar
  7. Shafritz, D.A., Shouval, D., Sherman, H.I., Hadziyannis, S.J. & Kew, M.C. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N. Engl. J. Med. 305, 1067–1073 (1981).
    Article CAS PubMed Google Scholar
  8. Koshy, R. et al. Integration of hepatitis B virus DNA: evidence for integration in the single-stranded gap. Cell 34, 215–223 (1983).
    Article CAS PubMed Google Scholar
  9. Brechot, C., Pourcel, C., Louise, A., Rain, B. & Tiollais, P. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286, 533–535 (1980).
    Article CAS PubMed Google Scholar
  10. Chakraborty, P.R., Ruiz-Opazo, N., Shouval, D. & Shafritz, D.A. Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line. Nature 286, 531–533 (1980).
    Article CAS PubMed Google Scholar
  11. Bonilla Guerrero, R. & Roberts, L.R. The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. J. Hepatol. 42, 760–777 (2005).
    Article CAS PubMed Google Scholar
  12. Murakami, Y. et al. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 54, 1162–1168 (2005).
    Article CAS PubMed PubMed Central Google Scholar
  13. Paterlini-Bréchot, P. et al. Hepatitis B virus–related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 22, 3911–3916 (2003).
    Article PubMed Google Scholar
  14. Gozuacik, D. et al. Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging. Oncogene 20, 6233–6240 (2001).
    Article CAS PubMed Google Scholar
  15. Saigo, K. et al. Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma. Hum. Mutat. 29, 703–708 (2008).
    Article CAS PubMed Google Scholar
  16. Ferber, M.J. et al. Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene 22, 3813–3820 (2003).
    Article CAS PubMed Google Scholar
  17. Neuveut, C., Wei, Y. & Buendia, M.A. Mechanisms of HBV-related hepatocarcinogenesis. J. Hepatol. 52, 594–604 (2010).
    Article CAS PubMed Google Scholar
  18. Totoki, Y. et al. High-resolution characterization of a hepatocellular carcinoma genome. Nat. Genet. 43, 464–469 (2011).
    Article CAS PubMed Google Scholar
  19. Li, M. et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat. Genet. 43, 828–829 (2011).
    Article CAS PubMed PubMed Central Google Scholar
  20. Furuta, T. et al. Clinicopathologic features of hepatocellular carcinoma in young patients. Cancer 66, 2395–2398 (1990).
    Article CAS PubMed Google Scholar
  21. Kim, J.H. et al. Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B–endemic area. J. Gastroenterol. Hepatol. 21, 588–594 (2006).
    Article PubMed Google Scholar
  22. Hao, K. et al. Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer 9, 389 (2009).
    Article PubMed PubMed Central Google Scholar
  23. Xu, X. et al. The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat. Biotechnol. 29, 735–741 (2011).
    Article CAS PubMed PubMed Central Google Scholar
  24. Chen, Y. et al. Complete genome sequence of hepatitis B virus (HBV) from a patient with fulminant hepatitis without precore and core promoter mutations: comparison with HBV from a patient with acute hepatitis infected from the same infectious source. J. Hepatol. 38, 84–90 (2003).
    Article CAS PubMed Google Scholar
  25. Trapnell, C., Pachter, L. & Salzberg, S.L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105–1111 (2009).
    Article CAS PubMed PubMed Central Google Scholar
  26. Mortazavi, A., Williams, B.A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621–628 (2008).
    Article CAS PubMed Google Scholar
  27. Lamb, J.R. et al. Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting. PLoS ONE 6, e20090 (2011).
    Article CAS PubMed PubMed Central Google Scholar
  28. Chiang, D.Y. et al. High-resolution mapping of copy-number alterations with massively parallel sequencing. Nat. Methods 6, 99–103 (2009).
    Article CAS PubMed Google Scholar
  29. Mermel, C.H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).
    Article PubMed PubMed Central Google Scholar

Download references

Acknowledgements

We gratefully acknowledge Y.-K. Mak and the clinical team of the Division of Hepatobiliary and Pancreatic Surgery (HBP) at Queen Mary Hospital. This study was funded by the Asian Cancer Research Group (ACRG), a not-for-profit organization formed by Eli Lilly, Merck and Pfizer. We thank S. Friend and G. Jin for initiating the establishment of ACRG. We are grateful to former and present members of ACRG, especially K. Blanchard, Y. Turpaz, J. Sedgwick, G. Tucker-Kellogg, G. Gilliland, P. Shaw, N. Gibson and S. Adams.

Author information

Author notes

  1. John M Luk
    Present address: Present address: Department of Oncology, Roche R&D Center (China) Ltd., Shanghai, China.,
  2. Wing-Kin Sung, Hancheng Zheng, Shuyu Li, Ronghua Chen and Xiao Liu: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Surgery, University of Hong Kong, Hong Kong
    Wing-Kin Sung, Nikki P Lee, Kwong F Wong, Angela M Liu, Ronnie T Poon, Sheung Tat Fan, Kwong L Chan & John M Luk
  2. School of Computing, National University of Singapore (NUS), Singapore
    Wing-Kin Sung & Chandana Tennakoon
  3. NUS Graduate School for Integrative Sciences & Engineering, National University of Singapore, Singapore
    Wing-Kin Sung & Chandana Tennakoon
  4. Department of Computational & Systems Biology, Genome Institute of Singapore, Singapore
    Wing-Kin Sung, Wah H Lee, Pramila N Ariyaratne & Fabianus H Mulawadi
  5. Beijing Genomics Institute, Shenzhen, China
    Hancheng Zheng, Xiao Liu, Yingrui Li, Zhuolin Gong, Yujie Hu, Zhao Lin, Guan Wang, Qinghui Zhang & Jun Wang
  6. Eli Lilly & Co., Indianapolis, Indiana, USA
    Shuyu Li, Thomas D Barber, Wen-Chi Chou, Amit Aggarwal & Christoph Reinhard
  7. Merck Research Laboratories, Boston, Massachusetts, USA
    Ronghua Chen, Ke Hao, Wei Zhou, Chunsheng Zhang, James Hardwick, Carolyn Buser & Hongyue Dai
  8. Department of Pharmacology, NUS, Singapore
    Kwong F Wong, Angela M Liu & John M Luk
  9. Department of Surgery, NUS, Singapore
    Kwong F Wong, Angela M Liu & John M Luk
  10. Cancer Science Institute, NUS, Singapore
    Kwong F Wong, Angela M Liu & John M Luk
  11. Asian Cancer Research Group, Inc., Wilmington, Delaware, USA
    James Hardwick & Mao Mao
  12. Pfizer Oncology, San Diego, California, USA
    Jiangchun Xu, Zhengyan Kan & Mao Mao
  13. Department of Biology, University of Copenhagen, Copenhagen, Denmark
    Jun Wang
  14. The Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark
    Jun Wang

Authors

  1. Wing-Kin Sung
    You can also search for this author inPubMed Google Scholar
  2. Hancheng Zheng
    You can also search for this author inPubMed Google Scholar
  3. Shuyu Li
    You can also search for this author inPubMed Google Scholar
  4. Ronghua Chen
    You can also search for this author inPubMed Google Scholar
  5. Xiao Liu
    You can also search for this author inPubMed Google Scholar
  6. Yingrui Li
    You can also search for this author inPubMed Google Scholar
  7. Nikki P Lee
    You can also search for this author inPubMed Google Scholar
  8. Wah H Lee
    You can also search for this author inPubMed Google Scholar
  9. Pramila N Ariyaratne
    You can also search for this author inPubMed Google Scholar
  10. Chandana Tennakoon
    You can also search for this author inPubMed Google Scholar
  11. Fabianus H Mulawadi
    You can also search for this author inPubMed Google Scholar
  12. Kwong F Wong
    You can also search for this author inPubMed Google Scholar
  13. Angela M Liu
    You can also search for this author inPubMed Google Scholar
  14. Ronnie T Poon
    You can also search for this author inPubMed Google Scholar
  15. Sheung Tat Fan
    You can also search for this author inPubMed Google Scholar
  16. Kwong L Chan
    You can also search for this author inPubMed Google Scholar
  17. Zhuolin Gong
    You can also search for this author inPubMed Google Scholar
  18. Yujie Hu
    You can also search for this author inPubMed Google Scholar
  19. Zhao Lin
    You can also search for this author inPubMed Google Scholar
  20. Guan Wang
    You can also search for this author inPubMed Google Scholar
  21. Qinghui Zhang
    You can also search for this author inPubMed Google Scholar
  22. Thomas D Barber
    You can also search for this author inPubMed Google Scholar
  23. Wen-Chi Chou
    You can also search for this author inPubMed Google Scholar
  24. Amit Aggarwal
    You can also search for this author inPubMed Google Scholar
  25. Ke Hao
    You can also search for this author inPubMed Google Scholar
  26. Wei Zhou
    You can also search for this author inPubMed Google Scholar
  27. Chunsheng Zhang
    You can also search for this author inPubMed Google Scholar
  28. James Hardwick
    You can also search for this author inPubMed Google Scholar
  29. Carolyn Buser
    You can also search for this author inPubMed Google Scholar
  30. Jiangchun Xu
    You can also search for this author inPubMed Google Scholar
  31. Zhengyan Kan
    You can also search for this author inPubMed Google Scholar
  32. Hongyue Dai
    You can also search for this author inPubMed Google Scholar
  33. Mao Mao
    You can also search for this author inPubMed Google Scholar
  34. Christoph Reinhard
    You can also search for this author inPubMed Google Scholar
  35. Jun Wang
    You can also search for this author inPubMed Google Scholar
  36. John M Luk
    You can also search for this author inPubMed Google Scholar

Corresponding authors

Correspondence toChristoph Reinhard, Jun Wang or John M Luk.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

About this article

Cite this article

Sung, WK., Zheng, H., Li, S. et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.Nat Genet 44, 765–769 (2012). https://doi.org/10.1038/ng.2295

Download citation

This article is cited by